HALOPERIDOL INJ
Clinical Criteria Summary
Transitioning Veteran
- Veteran is transitioning care from the Department of Defense to VHA, and a VA prescriber has determined continuing the medication is safe and clinically appropriate after assessing and consulting with the Veteran. (If met, remainder of criteria for use is not applicable.)
Exclusion Criteria
- Patient has never taken the long-acting injectable antipsychotic ordered in any formulation (e.g., oral).
- Patient has a hypersensitivity to the antipsychotic ordered.
Inclusion Criteria (All Must Be Met)
- Diagnosis of schizophrenia or schizoaffective disorder, or bipolar disorder.
- Prescriber is a VA Mental Health Provider.
- Patient has taken and tolerated the antipsychotic ordered prior to receiving it as a LAI for an adequate length of time.
- Patient will be transitioned from oral/short-acting injection medication to the long-acting injectable per guidelines/manufacturer recommendations.
Inclusion Criteria (One Must Be Met)
- Patient has relapsed or been hospitalized for the intended indication or complications of the intended indication because of nonadherence when treated with oral antipsychotics.
- Patient’s care environment is such that a LAI is a more reliable route of administration (e.g., homeless, lack of medication supervision, or medication cannot be stored safely).